The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer

Based on these data, we suggest that DNA damage levels measured in PBMCs of patients with BC may potentially represent a prognostic marker associated with poor survival; further validation is needed to better stratify patients with BC for clinical trials.